Auro Laboratories Ltd vs Remedium Lifecare Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Auro Laboratories Ltd is ₹ 249.05 as of 05 May 15:30 . The P/E Ratio of Auro Laboratories Ltd is 0 as of March 2025 .The P/E Ratio of Remedium Lifecare Ltd is 36.4 as of March 2025 . The Market Cap of Auro Laboratories Ltd is ₹ 0 crore as of March 2025 .The Market Cap of Remedium Lifecare Ltd is ₹ 73.38 crore as of March 2025 . The revenue of Auro Laboratories Ltd for the Sep '25 is ₹ 9.81 crore as compare to the Jun '25 revenue of ₹ 3.19 crore. This represent the growth of 207.52% The revenue of Remedium Lifecare Ltd for the Sep '25 is ₹ 114.31 crore as compare to the Jun '25 revenue of ₹ 116.84 crore. This represent the decline of -2.17% The ebitda of Auro Laboratories Ltd for the Sep '25 is ₹ 3.33 crore as compare to the Jun '25 ebitda of ₹ 0.45 crore. This represent the growth of 640% The ebitda of Remedium Lifecare Ltd for the Sep '25 is ₹ 10.62 crore as compare to the Jun '25 ebitda of ₹ 5.35 crore. This represent the growth of 98.5% The net profit of Auro Laboratories Ltd changed from ₹ 0.75 crore to ₹ 0.72 crore over 5 quarters. This represents a CAGR of -3.21% The net profit of Remedium Lifecare Ltd changed from ₹ -2.05 crore to ₹ 8.62 crore over 3 quarters. This represents a CAGR of NaN% The Dividend Payout of Auro Laboratories Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Remedium Lifecare Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Auro Laboratories Ltd

Auro Laboratories Limited, founded in 1992, has been manufacturing and providing generic Active Pharmaceutical Ingredients (API).
Currently, the Company is specializing in producing Anti Diabetics like Metformin HCL. It is the first-line treatment for type 2 diabetes.
The Company is headquartered in Mumbai and it has manufacturing facility at Palghar in Maharashtra.
The facility has all the required certifications from Indian authorities and European registration organization Since inception, the Company focused on providing quality pharmaceuticals while maintaining high manufacturing standards.
Company presently has 1800 MTPA of Metformin HCL manufacturing capacity, with projects underway to expand the capacity to 3600 MTPA. The Company's primary focus was on Anti-Diabetic Drugs, which estimated to be one of the fastest growing therapeutic segments.

About Remedium Lifecare Ltd

Remedium Lifecare Limited (Formerly known as 'Roxy Exports Limited) was incorporated in February 19, 1988.
Consequent to change in the business activities and accordingly, in order to keep the name of the Company in consonance with the new business activities, the Company changed its name from 'Roxy Exports Limited' to 'Remedium Lifecare Limited' vide a fresh Certificate of Incorporation on November 6, 2020 issued by the Registrar of Companies. The Company being a pharmaceutical company is aligned across two business verticals viz. products and services.
Products business comprises trading and sale of APIs and Intermediates to innovator and generic pharmaceutical players in both domestic and international markets including the regulated markets. Apart from this, the Company is engaged in the business of trading in Advanced Pharmaceutical Intermediates, Active Pharmaceutical Ingredients (API's) and other pharma products used viz.

FAQs for the comparison of Auro Laboratories Ltd and Remedium Lifecare Ltd

Which company has a larger market capitalization, Auro Laboratories Ltd or Remedium Lifecare Ltd?

Market cap of Auro Laboratories Ltd is 155 Cr while Market cap of Remedium Lifecare Ltd is 38 Cr

What are the key factors driving the stock performance of Auro Laboratories Ltd and Remedium Lifecare Ltd?

The stock performance of Auro Laboratories Ltd and Remedium Lifecare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Auro Laboratories Ltd and Remedium Lifecare Ltd?

As of May 5, 2026, the Auro Laboratories Ltd stock price is INR ₹249.05. On the other hand, Remedium Lifecare Ltd stock price is INR ₹0.44.

How do dividend payouts of Auro Laboratories Ltd and Remedium Lifecare Ltd compare?

To compare the dividend payouts of Auro Laboratories Ltd and Remedium Lifecare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.